UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 157,059 Shares of HCA Healthcare, Inc. $HCA

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,559,356 shares of the company’s stock after selling 157,059 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in HCA Healthcare were worth $728,001,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at about $26,000. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at about $29,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare during the third quarter valued at about $33,000. Finally, Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at about $34,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 2.3%

NYSE:HCA opened at $387.25 on Friday. The company’s 50 day moving average price is $429.60 and its 200-day moving average price is $473.48. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The stock has a market cap of $85.91 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.20 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Stephens reduced their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Leerink Partners reduced their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Barclays cut their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Finally, JPMorgan Chase & Co. cut their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.